Previous Article | Next Article 
J Virol, May 1998, p. 4022-4031, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Two Types of Virus-Related Particles Are Found
during Transmissible Gastroenteritis Virus Morphogenesis
Cristina
Risco,1
María
Muntión,2
Luis
Enjuanes,2 and
José L.
Carrascosa1,*
Departments of Macromolecular
Structure1 and
Molecular and Cell
Biology,2 Centro Nacional de
Biotecnología (CSIC), Campus Universidad Autónoma, 28049 Madrid, Spain
Received 11 November 1997/Accepted 3 February 1998
 |
ABSTRACT |
The intracellular assembly of the transmissible gastroenteritis
coronavirus (TGEV) was studied in infected swine testis (ST) cells at
different postinfection times by using ultrathin sections of
conventionally embedded infected cells, freeze-substitution, and
methods for detecting viral proteins and RNA at the electron microscopy
level. This ultrastructural analysis was focused on the identification
of the different viral components that assemble in infected cells, in
particular the spherical, potentially icosahedral internal core, a new
structural element of the extracellular infectious coronavirus recently
characterized by our group. Typical budding profiles and two types of
virion-related particles were detected in TGEV-infected cells. While
large virions with an electron-dense internal periphery and a clear
central area are abundant at perinuclear regions, smaller viral
particles, with the characteristic morphology of extracellular virions
(exhibiting compact internal cores with polygonal contours) accumulate
inside secretory vesicles that reach the plasma membrane. The two types
of virions coexist in the Golgi complex of infected ST cells. In
nocodazole-treated infected cells, the two types of virions coexist in
altered Golgi stacks, while the large secretory vesicles filled with
virions found in normal infections are not detected in this case.
Treatment of infected cells with the Golgi complex-disrupting agent
brefeldin A induced the accumulation of large virions in the cisternae
that form by fusion of different membranous compartments. These data, together with the distribution of both types of virions in different cellular compartments, strongly suggest that the large virions are the
precursors of the small viral particles and that their transport
through a functional Golgi complex is necessary for viral maturation.
 |
INTRODUCTION |
Coronaviruses are a group of large,
enveloped RNA viruses involved in a number of serious diseases that
affect mammals and birds (15, 43). These viruses have a
simple protein composition. Basically, four to five protein species
make up the infectious viral particle, with some variation in the
different members of the family: S and M glycoproteins are inserted in
the viral envelope (36, 56), as well as the small membrane E
protein, a minor component recently identified (20, 41, 67).
Some members of the Coronaviridae family contain an
additional envelope protein, the hemagglutinin esterase (HE) (32,
57). The nucleocapsid (N) protein is located inside the virion
and forms a complex with the viral RNA (29). Molecules of N
protein also seem to be part of the internal core shell recently found
in coronaviruses (52).
Morphogenesis of coronaviruses takes place in the cytoplasm of the
infected cell, with the participation of different membranous compartments, as established from the early ultrastructural studies of
coronavirus-infected cells (2, 12-14, 24). Early in
infection, shortly after the appearance of M and S proteins, the first
progeny virions are seen by electron microscopy (EM) in the perinuclear region of the cell (62-64). Viral morphogenesis starts with
the assembly of a helical nucleocapsid, made up of viral RNA and the nucleocapsid N protein (13, 58, 59). It is not known whether this nucleocapsid is preformed within the cytoplasm and rapidly transported to the membranes where assembly occurs or whether it is
assembled in association with cellular membranes. The nucleocapsid associates with smooth membranes belonging to the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) that constitute the
"budding compartment" for coronaviruses (35). This
compartment, which ultrastructurally resembles the transitional
elements at the rough endoplasmic reticulum now identified in a variety
of cells (23), contains both perinuclear and peripheral
elements (55). A structural analysis of cells infected with
infectious bronchitis virus, transmissible gastroenteritis coronavirus
(TGEV), or feline infectious peritonitis virus revealed that these
viruses also use the smooth perinuclear membranes (33),
although some budding in the Golgi complex has been occasionally
detected in mouse hepatitis virus (MHV)-infected cells. Although
molecular details of the budding process have not yet been elucidated,
it has been demonstrated that the M protein, which is essential for assembly, accumulates locally in the ERGIC membranes and probably reaches a concentration high enough to be recognized by the
nucleocapsids (53). This association would trigger the
budding process, which most probably involves the collective
incorporation of all other viral envelope proteins. The minor envelope
E protein, which is not fully characterized, also plays a crucial role
in assembly (6), although its nature has not been yet
elucidated. This budding process gives rise to virions that are
transported to and through the Golgi complex by vesicular carriers
(35). In the Golgi complex, the viral particles are usually
seen only at the rims of the stacks and at the trans side, and the
virions are collected into vesicles of the constitutive exocytic
pathway and released from the cell. Tooze et al. (63)
described the existence of two different morphologies for MHV-A59 viral
particles in infected AtT20 cells. Virions in the trans-Golgi network
were often kidney shaped and had a fairly uniform and high electron density, while virions in the Golgi cisternae and pre-Golgi
compartments were spherical and exhibited an "empty" center. Once
released from the cell, coronavirions tend to attach to the plasma
membrane, forming dense mats of adsorbed virions.
Our group has recently identified a new structural element in purified
virions from two coronaviruses, TGEV and MHV (52). An
internal core, potentially icosahedral, that contains the helical nucleocapsid, was visualized in intact virions, and after a
purification procedure for the cores was established, their structure
and protein composition were characterized (52). Since the
internal core shell represents a new structural element in the sequence
of coronavirus assembly, its formation in infected cells must involve
some as yet undefined steps in coronavirus morphogenesis that need to be revisited. In the last 10 years, methods that preserve cellular and
viral ultrastructure and that detect macromolecules at the EM level
have been developed and proving to be very useful tools in
understanding viral structure and morphogenesis (5, 9, 21, 22, 26,
27, 49). We have studied the morphogenesis of the TGEV and
started to define the different types of viral particles that assemble
inside infected cells, as well as the cellular elements potentially
involved in viral maturation.
 |
MATERIALS AND METHODS |
Cells, viruses, and antibodies.
TGEV virions (PUR46-MAD
strain) were purified from infected cultures of swine testis (ST)
cells. Cell culture, virus infections, and purification of TGEV were
performed as previously described (28). Monolayers of ST
cells were infected with TGEV at a multiplicity of infection of 10 PFU/cell and collected at different times (1, 2, 3, 4, 5, 6, 8, 10, 12, and 24 h) after fixation for EM (see below). The murine monoclonal
antibodies specific for TGEV proteins have been described previously
(18, 51, 54). Hyperimmune serum against the PUR46-MAD strain
of TGEV was raised in rabbits (28). Colloidal gold
conjugates of goat anti-mouse and goat anti-rabbit immunoglobulin G
were provided by Biocell Research Laboratory (Cardiff, United Kingdom).
Electron microscopy. (i) Processing of infected ST cells for
embedding in EML-812.
Monolayers of control ST cells and cells
infected with TGEV (at the postinfection (p.i.) times indicated in the
previous paragraph) were fixed in situ with a mixture of 2%
glutaraldehyde and 2% tannic acid in 0.4 M HEPES buffer (pH 7.5) for
1 h at room temperature. Fixed monolayers were removed from the
dishes in the fixative and transferred to Eppendorf tubes. After
centrifugation in a microcentrifuge and washes with HEPES buffer, the
pellets were processed for embedding in EML-812 (EML Laboratories,
Berks, United Kingdom), an epoxy resin adequate for ultrastructural
studies, by methods previously established (48) with some
modifications, such as two postfixation steps to stabilize the lipids
and short dehydration at 4°C to minimize the extraction of soluble
components. Postfixation of the cells was done with a mixture of 1%
osmium tetroxide and 0.8% potassium ferricyanide in distilled water
for 1 h at 4°C. This mixture has been reported to provide high
levels of preservation and contrast of membranous organelles (45,
48). After washes with HEPES buffer, samples were treated with
2% uranyl acetate, which protects membranes from extraction during
dehydration (22), washed again, and dehydrated in increasing
concentrations of acetone (50, 70, 90, and 100%, 10 min each, at
4°C), and EML-812 was allowed to infiltrate the cells at room
temperature. Polymerization of the infiltrated samples was done at
60°C for 3 days. Ultrathin (20- to 30-nm-thick) sections of the
samples were stained with saturated uranyl acetate and lead citrate by
standard procedures. For RNA detection, infected cells were subjected
to a milder fixation (1% glutaraldehyde in phosphate-buffered saline
[PBS]) before being embedded in EML-812. No postfixation was applied
in this case. All samples were studied with a JEOL 1200 EX II electron microscope.
(ii) Treatment of infected ST cells with nocodazol and BFA.
Confluent monolayers of ST cells were infected with TGEV at a
multiplicity of infection of 10 PFU/cell, and at 4 h p.i.,
cultures were treated with the microtubular disrupting agent nocodazole (Sigma) at different concentrations (1, 3, 10, and 20 µM) and incubated for 4 h at 37°C. Cells were then fixed in situ with a
mixture of 2% glutaraldehyde and 2% tannic acid in HEPES buffer, washed, and kept at 4°C until use. Other cultures were treated for 2 or 4 h with the Golgi complex-disrupting agent brefeldin A (BFA)
(Sigma), which was added to the cultures at 4 h p.i. and at a
concentration of 1, 5, or 10 µg/ml. Some of these cultures were
incubated for 2 or 4 h more after BFA was removed. Cells were then
fixed with glutaraldehyde-tannic acid or maintained at 37°C for 2 or
4 h after replacing the culture medium by a fresh one without the
drugs. At the times indicated, cells were fixed and processed for
embedding in EML-812, as described above.
(iii) Quick-freezing and freeze-substitution of fixed infected ST
cells.
Small pellets of fixed cells were cryoprotected with
glycerol, applied on small pieces of filter paper (1 mm2),
blotted for 15 s, and quick-frozen in liquid propane at an approximate speed of 104°C/s. Vitrified specimens were
stored in liquid nitrogen until use. For freeze-substitution, samples
were transferred to a Reichert Jung AFS freeze-substitution unit
(Leica, Vienna, Austria), and maintained for 24 h at
90°C in a
mixture of pure acetone and 0.5% (wt/vol) osmium tetroxide for a
complete substitution of the water of the sample by established
procedures (22, 46). After a controlled gradual increase of
the temperature, the cell samples were infiltrated with the epoxy resin
EML-812 and polymerized. Ultrathin sections were either stained with
uranyl acetate and lead citrate or processed for immunodetection of
viral proteins.
(iv) Detection of viral proteins and RNA.
Immunogold
labeling of TGEV proteins was done on ultrathin EML-812 sections of
infected ST cells by using monoclonal or polyclonal antibodies and
conjugates of secondary antibodies and 5- or 10-nm-diameter colloidal
gold particles, according to general procedures previously described in
detail (49-51). RNA from cellular and viral structures was
detected as previously described (3, 4) by using a conjugate of RNase and colloidal gold with a diameter of 10 nm provided by EY
Laboratories (San Diego, Calif.). Sections were incubated with the
RNase-gold conjugate diluted 1:40 in PBS (pH 7.5) for 30 min at room
temperature, washed with PBS and distilled water, and stained with
uranyl acetate and lead citrate. For a cytochemical control, some
sections were preincubated with a solution of nonconjugated RNase (20 µg/ml) before treating with the RNase-gold conjugate.
(v) Quantitative studies.
The size of the viral cores (the
dense internal component) was measured from electron micrographs of
freeze-substituted infected ST monolayers (6 h p.i.) (see Fig. 4). The
distribution of the different types of virions in different cellular
compartments (perinuclear area, Golgi complex, large secretory
vesicles, and extracellular cell surface) at different p.i. times was
also studied. The results are presented as the percentage of each viral
morphology in the indicated compartment (see Table 1). The effect of
nocodazol and BFA treatments on the intracellular accumulation of the
different types of virions was also studied, and the results are
summarized in Table 2. A total of 3,500 virions were included in these
quantitative studies.
 |
RESULTS |
Different TGEV assemblies in infected ST cells.
ST cells
infected with TGEV were studied at different p.i. times to understand
the early events in morphogenesis. At 4 h p.i., the earliest p.i.
time rendering sufficient amounts of virions to be studied by ultrathin
sections and EM, very few virions accumulate inside infected cells. At
5 and 6 h p.i., a progressive accumulation of intracellular viral
particles takes place, although the ultrastructure of the cells is
still indistinguishable from that of noninfected cells. At 8 and
10 h p.i., large amounts of intracellular and extracellular
virions can be seen. At longer times (24 h), large secretory vesicles
with many viruses and many extracellular virions are seen, together
with cellular alterations and cytoplasmic inclusions typical of late
p.i. times (12, 61). Five and 6 h p.i. were then
selected as the best times to analyze the early assembly events, well
before the overproduction of viral components and viral particles makes
interpretation more complicated.
Our analysis of the different viral assemblies that form in infected
cells has been done with ultrathin sections of conventionally embedded
infected cells and cells processed by freeze-substitution, a method
that allows a high level of preservation of fine structural details.
Certain fine details, such as the shape and size of cellular organelles, are better preserved by freeze-substitution, although conventional embedding methods provide better contrast of cellular membranes. This combination of data showed the existence of virions of
two different sizes and morphologies, both in freeze-substituted and
conventionally embedded samples (Fig.
1).
The earliest viral assembly distinguished inside infected cells
consisted of characteristic budding profiles or "maturation arcs"
(Fig. 1A). The budding profiles give rise to large virions that exhibit
an electron-dense internal periphery and a less dense central zone
(Fig. 1A). These virions, together with the budding profiles, are more
abundant in the perinuclear area of the cell but are also found in
smaller amounts at other locations. A different type of viral particle
accumulates in regions closer to the plasma membrane. These particles
are smaller and contain a dense core (Fig. 1B). The structure and
dimensions of the internal core of these virions (diameter of around 60 nm) are identical to the corresponding cores found in extracellular viral particles (Fig. 1C). Only a small amount of large viral particles
exit the cells (Fig. 1D); these virions constitute a minor component of
the extracellular population of virions (see below).

View larger version (147K):
[in this window]
[in a new window]
|
FIG. 1.
TGEV virions in different regions of infected ST
cells. Sections of freeze-substituted cells (A to C) and a
conventionally embedded cell (D) are shown. (A) Certain areas of the
infected cell, mainly close to the nucleus, accumulate characteristic
budding profiles (arrows) and large virions with an internal
electron-dense periphery and clear center (arrowheads). (B) Closer to
the plasma membrane, virions exhibit a smaller size and a homogeneously
dense internal core (arrows). Some of these viral cores clearly exhibit
polygonal contours (arrowheads). (C and D) Most of the extracellular
virions are small particles with dense cores (arrows), although a few
large viral particles are also seen in the extracellular environment
(arrowhead in panel D). Abbreviations: sv, secretory vesicle; ci,
cilium; pm, plasma membrane; mv, microvilli. Bar, 200 nm.
|
|
Figure
2 is a summary of the different
TGEV-related assemblies detected in infected ST cells. Budding profiles
contain a dense
cytoplasmic element (presumably the helical
nucleocapsid) and
exhibit different stages from flat forms (Fig.
2A) to
curved structures
(Fig.
2B), some with cytoplasmic "tails" (Fig.
2C), to almost
spherical (Fig.
2D). Large spherical viral particles
originate
from the budding profiles (Fig.
2E and F). On the other hand,
smaller viral particles contain homogeneously dense cores (Fig.
2G and
H), characteristic of extracellular virions. We obtained
the first
evidence of a potentially icosahedral internal core
in the small
virions with freeze-substituted cells, since a polygonal
periphery is
distinguished in some of the sectioned particles
(Fig.
1B and
2G and
H). All the described viral assemblies were
unequivocally identified as
related to TGEV, since they all reacted
with polyclonal anti-TGEV
antibodies (Fig.
2I and J), and they
were always associated with the
membrane. Several monoclonal antibodies
specific for the TGEV M, N, and
S proteins also reacted with the
two different types of viral particles
(not shown).

View larger version (201K):
[in this window]
[in a new window]
|
FIG. 2.
Collection of images corresponding to the different
TGEV-related assemblies detected in infected ST cells. Sections of
conventionally embedded cells (A, C, D, and I) and fixed,
freeze-substituted cells (B, E, F, G, H, and J) are shown. (A to D)
Different stages of the budding profiles. All stages present a dense
cytoplasmic structure (arrows) interacting with smooth-walled membranes
(arrowheads) and a variable curvature, from flat (A) to almost
spherical (D). In panel C, part of the dense material is apparently not
interacting with the membrane and looks like a cytoplasmic tail
(arrow). Budding profiles originate large spherical viral particles
with an electron-dense internal periphery and a clear center (E and F).
Smaller virions have an internal dense core that frequently exhibit
polygonal contours (arrows in panels G and H). Budding profiles (arrow
in panel I) and both large and small viral particles (I and J) react
with polyclonal anti-TGEV antibodies, as shown by immunogold labeling.
Bar, 100 nm.
|
|
Large and small viral particles also bound a conjugate of RNase-gold
(Fig.
3), used to detect RNA-containing
structures at
the EM level (
3,
4). This conjugate reacted
with RNA-containing
cellular structures, such as ribosomes (Fig.
3A)
and nucleoli
(not shown). The conjugate reacted with the small viral
particles
and the dense periphery of large virions (Fig.
3B).
Pretreatment
of the sections with nonconjugated RNase totally inhibited
the
binding of the RNase-gold complex to viral particles and to
RNA-containing
cellular components (Fig.
3C and D).

View larger version (199K):
[in this window]
[in a new window]
|
FIG. 3.
Binding of an RNase-gold complex to sections of infected
ST cells. (A) The signal concentrates on RNA-containing cellular
structures, such as, for example, the rough endoplasmic reticulum
(RER)-associated ribosomes and free ribosomes. Binding to individual
ribosomes is distinguished (arrows). Some signal on mitochondria (mi)
is also detected. (B) This RNase-gold complex also reacts with both
small (arrows) and large (arrowheads) virions. The RNA-gold probe binds
to the dense periphery of large virions. Pretreatment of the sections
with nonconjugated RNase (20 µg/ml) abolished the subsequent binding
of the RNase-gold complex to both RNA-containing cellular structures
(C) and to TGEV particles (labeled v in panel D). r, ribosome; SV,
secretory vesicle. Bar, 200 nm.
|
|
Using freeze-substituted infected ST cells, we measured the size of the
dense internal component of the viral particles (the
structures
contrasted better in these samples) and the size distribution
obtained
is shown in Fig.
4. Considering the small
differences
in diameter caused by the plane of section, two main sizes
account
for more than 80% of the whole population of virions. In
extracellular
virions, most of the viral cores correspond to the
smaller size
(diameter, 50 to 65 nm), while a population of large
particles
(68 to 80 nm) is found in intracellular virions. Also, minor
components
appeared after this quantitative study: a small percentage
(4%)
of bigger particles (>80- to 92-nm diameter) and a small
percentage
of virions (1 to 5%, depending on the p.i. time) that did
not
correspond to the two morphologies described. We found large
particles
with a homogeneous, highly dense content, small virions with
an
annular, dense internal structure, and virions with an undefined
internal structure of apparently low density. They could constitute
potential intermediary assemblies, although their significance
remains
to be established.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
Size distribution of TGEV cores in viral particles from
ultrathin sections of TGEV-infected cells. Only intracellular virions
from freeze-substituted samples were included in the quantification.
The percentage of viral cores with a defined diameter is represented.
Core size (diameter [in nanometers]) classes were established as
follows: 1, <36; 2, >36 to 38; 3, >38 to 41; 4, >41 to 44; 5, >44
to 47; 6, >47 to 50; 7, >50 to 53; 8, >53 to 56; 9, >56 to 59; 10, >59 to 62; 11, >62 to 65; 12, >65 to 68; 13, >68 to 71; 14, >71 to
74; 15, >74 to 77; 16, >77 to 80; 17, >80 to 83; 18, >83 to 86; 19, >86 to 89; 20, >89. Virions belonging to the two extremes of the core
size distribution are shown in the two micrographs: the small virion on
the left corresponds to class 8, while the large virion on the right
corresponds to class 19. A total of 505 virions were included in the
measurements.
|
|
The distribution of large and small virions in different cellular
regions and compartments was analyzed (Table
1). This quantification
indicated that
large virions are more abundant in the perinuclear
area, known to be
rich in ERGIC-related elements, while both large
and small virions
coexist in the Golgi complex (Table
1 and Fig.
5A). Post-Golgi complex
large secretory vesicles contain mainly
small dense virions, the
morphology that corresponds to that of
the majority of the
extracellular population of virions (Table
1). These data suggest that
the large annular virions are precursors
of the small viral particles
and that the major structural transformation
that yields the small
virions could depend on the transport of
TGEV particles through the
Golgi complex of ST cells.
Effects of BFA and nocodazole on TGEV assembly.
The
intracellular distribution of the two types of TGEV particles strongly
suggests an association between intracellular transport through the
constitutive secretory pathway and the structural maturation of
virions. To test this possibility, we analyzed the effects of two drugs
that disrupt the exocytic pathway (BFA and nocodazole) on viral
assembly. BFA acts within minutes, inducing a rapid redistribution of
Golgi cisternae into the endoplasmic reticulum, leaving no definable
Golgi structure (17, 39, 40). This dramatic effect on the
endoplasmic reticulum and Golgi systems occurs without affecting other
cellular processes, including protein synthesis. At 4 h p.i., when
few virions accumulate, infected ST cells were treated with BFA as
described in Materials and Methods. The disappearance of the Golgi
complex was associated with the formation of large cisternae that most
probably result from the fusion between different membranous
compartments (Fig. 5). While both large
and small virions coexist in the Golgi apparatus from normal infected
cells (Fig. 5A), most of the TGEV particles visualized inside the large
cisternae of BFA-treated infected cells are large virions with a very
electron-dense periphery and a less dense center (Fig. 5B and Table
2). A significantly higher amount of budding profiles was seen in these cells than in normally infected cell
cultures (Table 2). Removal of BFA from these cultures did not lead to
a recovery of cellular internal organization and TGEV release when
cells were maintained 2 or 4 h more in the absence of the drug.
Large annular virions kept accumulating inside large cisternae under
these conditions (not shown).

View larger version (180K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of BFA and nocodazole treatment on TGEV assembly.
(A) Large virions (arrowheads) and small dense viral particles (arrows)
coexist within the Golgi complex (G) of normal infected cells. (B) BFA
causes the disappearance of the Golgi complex as a distinguishable
structure, together with the formation of large cisternae (asterisks),
some of them apparently derived from the rough endoplasmic reticulum
(RER), since they have ribosomes (r) attached. TGEV virions assemble in
association with these cisternae (arrowheads point to budding
profiles). Large viral particles with an electron-dense internal
periphery and clear center (arrows) accumulate in these conditions.
Some ERGIC-like tubular membranes are visible in these cells (pairs of
arrows). (C) Abnormal Golgi stack (G) from a nocodazole-treated
infected ST cell. Both budding profiles (arrowheads) and small dense
virions (arrows) are seen within the altered membranes of the stack.
mi, mitochondria; pm, plasma membrane. Bar, 200 nm.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Percentages of large and small virions in infected ST
cells at different times and with
different treatmentsa
|
|
The addition of nocodazole to infected ST cells (4 h p.i.) apparently
arrested the transport of viral particles beyond the
Golgi apparatus.
The cytoplasm of cells affected by the nocodazole
treatment was less
organized, as shown by EM; no microtubules
were distinguished, and
there were smaller and dispersed Golgi
stacks (not shown). TGEV virions
were seen in these disrupted
Golgi stacks, and they exhibited the two
types of morphologies
described above (Fig.
5C and Table
1). Large
secretory vesicles
with numerous virions were not seen, and very few
virions were
detected on the extracellular surfaces of these cells (not
shown).
No differences in structure were observed in large and small
TGEV
virions assembled in the presence of nocodazole compared with
virions visualized in normally infected cells.
These results strongly suggest that precursor virions need to pass
through a functional Golgi complex to complete the structural
transformation that yields the small, infectious virions.
 |
DISCUSSION |
The morphogenesis of coronaviruses has been defined as a complex
process that involves different elements of the constitutive exocytic
pathway of the cell. Special interest resides in the events that take
place during the budding process and the subsequent construction of the
spherical, most probably icosahedral, core shell. In this study, we
have shown that two types of virus-related particles can be found in
TGEV-infected cells, large virions that form from budding profiles and
small viral particles that are identical to the extracellular
infectious virions characterized in our previous report
(52). The optimal structural preservation obtained in this
study and the confirmation provided by freeze-substitution have been
decisive in identifying the two types of TGEV virions in infected ST
cells. Moreover, our images strongly suggest that the morphology of the
small viral particles is closely related to the formation of the
internal core shell.
The morphological maturation described for TGEV represents a dramatic
decrease in the volume of the viral particle. Significant changes in
virion volume during maturation have been extensively described in the
morphogenesis of bacteriophages (8, 10, 31), although it
does not seem to be so frequent among animal viruses. Nevertheless,
there are cases in which a similar process has been also described. The
human immunodeficiency virus, for example, assembles large virions that
later transform into smaller viral particles with condensed internal
cores (19, 22). The process also represents a considerable
change in virion volume that must take place after the activation of
the viral protease. For TGEV, we have seen that the change in volume is
accompanied by a major redistribution of the dense intravirion material
that first occupies a peripheral position and after maturation becomes homogeneously distributed inside the smaller condensed core. This dense
material most probably contains the viral RNA, as suggested by the
signal provided by the RNase-gold complex and the data obtained in
another study, in which phosphorous elemental maps have been proposed
to represent the direct locations of nucleic acids in viruses
(47).
What are the stimuli that trigger TGEV structural maturation inside ST
cells? Our data point to a close association between intracellular
transport through the exocytic constitutive pathway and viral
maturation. In this sense, Tooze et al. (63) reported the
existence of two types of virions in AtT20 cells infected by the
MHV-A59 coronavirus. While spherical large virions were visualized in
pre-Golgi compartments and in Golgi cisternae, smaller, kidney-shaped,
very electron-dense viral particles were detected in the trans-Golgi
network. Although the mentioned kidney shape could be the result of a
deformation suffered by the small viral particles, the morphological
maturation described for MHV seems to be very similar to the process in
TGEV that we detected. The data we have obtained in infected cells
treated with BFA or nocodazole also support the possibility that viral
maturation is taking place in the Golgi complex. Nocodazole treatment
was chosen to study the effects that a blockade of the exocytic pathway
at a post-Golgi level could have on viral morphology. The results of
experiments with live cells and microtubule inhibitors (1,
7) suggest that microtubules facilitate the transport of vesicles
between the Golgi apparatus and the plasma membrane, while the movement of membrane out of the endoplasmic reticulum toward the Golgi complex
is believed to occur by a microtubule-independent mechanism (39). It is also known that nocodazole treatment causes a
reversible fragmentation of the Golgi complex into numerous
dispersed units that remain functional (65). In
nocodazole-treated, infected ST cells, TGEV virions are able to reach
these modified Golgi stacks and undergo structural maturation. The
assembly seems, however, to be retarded, since fewer small virions
accumulate with time (Table 1). On the other hand, BFA was used to
analyze the morphology of TGEV particles assembled in the absence of a functional Golgi complex. Large "precursor" virions accumulated in
these cells. Although it has been reported that cells appear to
metabolize BFA (11), at the lower BFA concentration used in
our experiments (1 µg/ml), the effects of BFA treatment on the
organization of ST cells and release of TGEV were not reversible 4 h after the drug was removed. Large annular virions kept accumulating inside the large cisternae under these conditions. It is likely that
the prolonged treatment with BFA needed to accumulate virions makes the
effect of the drug irreversible in ST cells. We have observed
(52a) that the effects on cellular ultrastructure were less
dramatic when BFA was added after a 30-min incubation with nocodazole,
probably because BFA-induced fusion between different membranous
compartments partly depends on microtubules, as proposed by
Lippincott-Schwartz et al. (39). Four hours after both drugs were removed, a partial recovery of intracellular organization was
seen, together with an increase in the amount of small dense virions
(up to 30% of the total population of virions). Virus secretion,
however, was not recovered.
To this point we have no data on whether cellular factors are
responsible for viral morphological maturation or whether specific virus-associated elements are activated during intracellular transport. A combination of both is also possible, as in the case of alphaviruses. One of the viral polyproteins of Sindbis virus is processed by the
combined action of an autoproteolytic activity in the capsid protein, a
cellular signal peptidase, and an enzyme thought to be a component of
the Golgi apparatus (60). Maturation through a proteolytic
processing has the advantage of being an irreversible process, as
extensively documented, for example, in bacteriophages (8)
and retroviruses (30, 34). In coronaviruses, no enzymatic activity associated to purified coronavirus particles has been reported
to date. However, the large intracellular precursor virions have not
been purified and characterized in vitro. Since new virus-associated proteins are being reported (16) and still several open
reading frames remain to be defined (56), minor, yet
unidentified virus-associated proteins could exist and be involved in
the maturation process. The E envelope protein is, for example, a key
element in assembly, being synthesized in ample amounts in infected
cells but incorporated into extracellular virions in only minor amounts
(53).
It has been proposed that proteolytic processing (25) and
dephosphorylation (37, 59) of the nucleocapsid (N) protein could play an important role in assembly. For TGEV M and S proteins, glycosylation is the only posttransductional modification known to take
place. Glycosylation of M is not a requirement for assembly, since a
mutant TGEV defective for glycosylation in M was able to assemble
normally and produce infectious virions (38). Correct glycosylation of S is necessary for its folding and incorporation into
infectious virions, but not for the assembly of viral particles (42). Glycosylation is not complete for all the protein
molecules within the viral particles, probably due to accessibility
problems for the enzymes in reaching all the modification sites, since they have to act on whole viral particles. Some similar mechanism could
explain why a small amount of virions "escape" from the maturation
process and exit the cell, constituting a minor component of the
extracellular population of virions. The participation of these or some
other processes in the morphogenesis of coronaviruses should be studied
in detail, and to this end, the purification of the large precursor
virions will be of great interest.
Recent studies focused on the association between the coronavirus
envelope proteins and the formation of virus-like particles in vitro
have identified some of the molecular requirements for building
pseudo-viral envelopes (44, 66). Lateral interactions between the M and E envelope proteins within the lipid bilayer seem to
constitute the driving force for the assembly of these particles.
Although they can contain variable amounts of the different envelope
proteins, the sizes of the envelopes assembled under these conditions
are surprisingly similar to those of whole virions (66).
Although these processes are far from the natural morphogenetic pathway, they can be of interest in understanding the particular roles
and assembly capabilities of the isolated structural components.
The detailed structural analysis presented here shows new aspects of
the morphogenesis of coronaviruses. Further studies are necessary for
defining its molecular basis and its potential application in the in
vitro manipulation of assembly. The potential existence of other
intermediates in the sequence of assembly should also be defined. These
studies are presently under way.
 |
ACKNOWLEDGMENTS |
This work was partly supported by grant PB96-0818 from the
Comisión Interministerial de Ciencia y Tecnología to
J.L.C. and by grants from the Comisión Interministerial de
Ciencia y Tecnología and the European Union (projects Science
and Biotech) to L.E. C. Risco is the recipient of a contract from
the C.S.I.C.-Fundación Ramón Areces.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Macromolecular Structure, Centro Nacional de Biotecnología
(CSIC), Campus Universidad Autónoma, Cantoblanco, 28049 Madrid,
Spain. Phone: 341-5854509. Fax: 341-5854506. E-mail:
jlcarrascosa{at}cnb.uam.es.
 |
REFERENCES |
| 1.
|
Arnheiter, H.,
M. Dubois-Dalcq, and R. A. Lazzarini.
1984.
Direct visualization of protein transport and processing in the living cell by microinjection of specific antibodies.
Cell
39:99-109[Medline].
|
| 2.
|
Becker, W. B.,
K. McIntosh,
J. H. Dees, and R. M. Chanock.
1967.
Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229E).
J. Virol.
1:1019-1027[Abstract/Free Full Text].
|
| 3.
|
Bendayan, M.
1981.
Ultrastructural localization of nucleic acids by the use of enzyme-gold complexes.
J. Histochem. Cytochem.
29:531-541[Abstract].
|
| 4.
|
Bendayan, M.
1989.
The enzyme-gold cytochemical approach: a review, p. 117-147.
In
M. A. Hayat (ed.), Colloidal gold: principles, methods, and applications, vol. 2. Academic Press, Inc., San Diego, Calif.
|
| 5.
|
Booy, F. P.
1993.
Cryoelectron microscopy, p. 21-54.
In
J. Bentz (ed.), Viral fusion mechanisms. CRC Press, Inc., Boca Raton, Fla.
|
| 6.
|
Bos, E. C. W.,
W. Luytjes,
H. Van der Meulen,
H. K. Koerten, and W. J. M. Spaan.
1996.
The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus.
Virology
218:52-60[Medline].
|
| 7.
|
Burguess, T. L., and R. B. Kelly.
1987.
Constitutive and regulated secretion of proteins.
Annu. Rev. Cell Biol.
3:243-293.
|
| 8.
|
Carrascosa, J. L.
1986.
Bacteriophage morphogenesis, p. 37-70.
In
J. R. Harris, and R. W. Horne (ed.), Electron microscopy of proteins, vol. 5. Academic Press, London, England.
|
| 9.
|
Carrascosa, J. L.
1988.
Immunoelectron microscopical studies on viruses.
Electron Microsc. Rev.
1:1-16[Medline].
|
| 10.
|
Casjens, S., and R. W. Hendrix.
1988.
Control mechanisms in dsDNA bacteriophage assembly, p. 15-90.
In
R. Calendar (ed.), The bacteriophages, vol. 1. Plenum Press, New York, N.Y.
|
| 11.
|
Chen, S.-Y.,
Y. Matsuoka, and R. W. Compans.
1991.
Assembly and polarized release of Punta Toro virus and effects of brefeldin A.
J. Virol.
65:1427-1439[Abstract/Free Full Text].
|
| 12.
|
David-Ferreira, J. F., and R. A. Manaker.
1965.
An electron microscope study on the development of a mouse hepatitis virus in tissue cells.
J. Cell Biol.
24:57-78[Abstract/Free Full Text].
|
| 13.
|
Dubois-Dalcq, M. E.,
E. W. Doller,
M. V. Haspel, and K. V. Holmes.
1982.
Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures.
Virology
119:317-331[Medline].
|
| 14.
|
Dubois-Dalcq, M. E.,
K. V. Holmes, and B. Rentier.
1984.
Assembly of coronaviruses, p. 100-119.
In
D. W. Kingsbury (ed.), Assembly of RNA viruses. Springer-Verlag, New York, N.Y.
|
| 15.
|
Enjuanes, L., and B. A. M. Van der Zeijst.
1995.
Molecular basis of the transmissible gastroenteritis virus epidemiology, p. 337-376.
In
S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
|
| 16.
|
Fischer, F.,
D. Peng,
S. T. Hingley,
S. R. Weiss, and P. S. Masters.
1997.
The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication.
J. Virol.
71:996-1003[Abstract].
|
| 17.
|
Fujiwara, T.,
K. Oda,
S. Yokota,
A. Takatsuki, and Y. Ikehara.
1988.
Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum.
J. Biol. Chem.
263:18545-18552[Abstract/Free Full Text].
|
| 18.
|
Gebauer, F.,
W. A. P. Posthumus,
I. Correa,
C. Suñé,
C. M. Sánchez,
C. Smerdou,
J. A. Lenstra,
R. Meloen, and L. Enjuanes.
1991.
Residues involved in the formation of the antigenic sites of the S protein of transmissible gastroenteritis coronavirus.
Virology
183:225-238[Medline].
|
| 19.
|
Gelderblom, H. R.,
M. Özel, and G. Pauli.
1989.
Morphogenesis and morphology of HIV. Structure-function relations.
Arch. Virol.
106:1-13[Medline].
|
| 20.
|
Godet, M.,
R. L'Haridon,
J.-F. Vautherot, and H. Laude.
1992.
TGEV coronavirus ORF4 encodes a membrane protein that is incorporated into virions.
Virology
188:666-675[Medline].
|
| 21.
|
Granzow, H.,
F. Weiland,
A. Jöns,
B. G. Klupp,
A. Karger, and T. C. Mettenleiter.
1997.
Ultrastructural analysis of the replication cycle of pseudorabies virus in cell culture: a reassessment.
J. Virol.
71:2072-2082[Abstract].
|
| 22.
|
Grief, C.,
M. V. Nermut, and D. J. Hockley.
1994.
A morphological and immunolabeling study of freeze-substituted human and simian immunodeficiency viruses.
Micron
25:119-128.
|
| 23.
|
Hauri, H. P., and A. Schweizer.
1992.
The endoplasmic reticulum-Golgi intermediate compartment.
Curr. Opin. Cell Biol.
4:600-608[Medline].
|
| 24.
|
Holmes, K. V., and J. N. Behnke.
1981.
Evolution of a coronavirus during persistent infection in vitro.
Adv. Exp. Med. Biol.
142:287-299[Medline].
|
| 25.
|
Holmes, K. V.,
J. F. Boyle,
R. K. Williams,
C. B. Stephensen,
S. G. Robbins,
E. C. Bauer,
C. S. Duchala,
M. F. Frana,
D. G. Weismiller,
S. Compton,
J. J. McGowan, and L. S. Sturman.
1987.
Processing of coronavirus proteins and assembly of virions, p. 339-349.
In
M. A. Brinton, and R. R. Rueckert (ed.), Positive strand RNA viruses. Alan R. Liss, New York, N.Y.
|
| 26.
|
Hyatt, A. D., and B. T. Eaton.
1990.
Virological applications of the grid-cell-culture technique.
Electron Microsc. Rev.
3:1-27[Medline].
|
| 27.
|
Jäntti, J.,
P. Hildén,
H. Rönkä,
V. Mäkiranta,
S. Keränen, and E. Kuismanen.
1997.
Immunocytochemical analysis of Uukuniemi virus budding compartments: role of the intermediate compartment and the Golgi stack in virus maturation.
J. Virol.
71:1162-1172[Abstract].
|
| 28.
|
Jiménez, G.,
I. Correa,
M. P. Melgosa,
M. J. Bullido, and L. Enjuanes.
1986.
Critical epitopes in transmissible gastroenteritis virus neutralization.
J. Virol.
60:131-139[Abstract/Free Full Text].
|
| 29.
|
Kapke, P. A., and D. A. Brian.
1986.
Sequence analysis of the porcine transmissible coronavirus nucleocapsid protein gene.
Virology
151:41-49[Medline].
|
| 30.
|
Katoh, I.,
Y. Yoshinaka,
A. Rein,
M. Shibuya,
T. Odaka, and S. Oroszlan.
1985.
Murine leukemia virus maturation: protease region required for conversion from immature to mature core form and for virus infectivity.
Virology
145:280-292[Medline].
|
| 31.
|
Kellenberger, E.
1990.
Form determination of the heads of bacteriophages.
Eur. J. Biochem.
190:233-248[Medline].
|
| 32.
|
King, B., and D. A. Brian.
1982.
Bovine coronavirus structural proteins.
J. Virol.
42:700-707[Abstract/Free Full Text].
|
| 33.
|
Klumperman, J.,
J. Krijnse Locker,
A. Meijer,
M. C. Horzinek,
H. J. Geuze, and P. J. M. Rottier.
1994.
Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding.
J. Virol.
68:6523-6534[Abstract/Free Full Text].
|
| 34.
|
Kohl, N. E.,
E. A. Emini,
W. A. Schleif,
L. J. Davis,
J. C. Heimbach,
R. A. F. Dixon,
E. M. Scolnick, and I. S. Sigal.
1988.
Active human immunodeficiency virus protease is required for viral infectivity.
Proc. Natl. Acad. Sci. USA
85:4686-4690[Abstract/Free Full Text].
|
| 35.
|
Krijnse-Locker, J.,
M. Ericsson,
P. J. Rottier, and G. Griffiths.
1994.
Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step.
J. Cell Biol.
124:55-70[Abstract/Free Full Text].
|
| 36.
|
Lai, M. M. C.
1990.
Coronavirus. Organization, replication, and expression of genome.
Annu. Rev. Microbiol.
44:303-333[Medline].
|
| 37.
|
Laude, H., and P. S. Masters.
1995.
The coronavirus nucleocapsid protein, p. 141-163.
In
S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
|
| 38.
|
Laude, H.,
J. Gelfi,
L. Lavenant, and B. Charley.
1992.
Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus.
J. Virol.
66:743-749[Abstract/Free Full Text].
|
| 39.
|
Lippincott-Schwartz, J.,
J. G. Donaldson,
A. Schweizer,
E. G. Berger,
H.-P. Hauri,
L. C. Yuan, and R. D. Klausner.
1990.
Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway.
Cell
60:821-836[Medline].
|
| 40.
|
Lippincott-Schwartz, J.,
L. C. Yuan,
J. S. Bonifacino, and R. D. Klausner.
1989.
Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER.
Cell
56:801-813[Medline].
|
| 41.
|
Liu, D. X., and S. C. Inglis.
1991.
Association of the infectious bronchitis virus 3c protein with the virion envelope.
Virology
185:911-917[Medline].
|
| 42.
|
Luytjes, W.,
H. Gerritsma,
E. Bos, and W. Spaan.
1997.
Characterization of two temperature-sensitive mutants of coronavirus mouse hepatitis virus strain A59 with maturation defects in the spike protein.
J. Virol.
71:949-955[Abstract].
|
| 43.
|
MacIntosh, K.
1996.
Coronaviruses, p. 1095-1133.
In
B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
|
| 44.
|
Opsteltein, D.-J.,
M. J. B. Raamsman,
K. Wolfs,
M. C. Horzinek, and P. J. Rottier.
1995.
Envelope glycoprotein interactions in coronavirus assembly.
J. Cell Biol.
131:339-349[Abstract/Free Full Text].
|
| 45.
|
Pimenta, P. F. P., and W. de Souza.
1985.
Fine structure and cytochemistry of the endoplasmic reticulum and its association with the plasma membrane of Leishmania mexicana.
J. Submicrosc. Cytol.
17:413-419[Medline].
|
| 46.
|
Quintana, C.
1994.
Cryofixation, cryosubstitution, cryoembedding for ultrastructural, immunocytochemical, and microanalytical studies.
Micron
25:63-99.
|
| 47.
| Quintana, C., S. Marco, N. Bonnet, C. Risco, M. L. Gutiérrez, A. Guerrero, and J. L. Carrascosa.
Phosphorous localization by EELS and image filtering in viruses.
Submitted for publication.
|
| 48.
|
Risco, C.,
C. Romero,
M. A. Bosch, and P. Pinto da Silva.
1994.
Type II pneumocytes revisited: intracellular membranous systems, surface characteristics, and lamellar body secretion.
Lab. Invest.
70:407-417[Medline].
|
| 49.
|
Risco, C.,
L. Menéndez-Arias,
T. D. Copeland,
P. Pinto da Silva, and S. Oroszlan.
1995.
Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of the nucleocapsid protein and integrase.
J. Cell Sci.
108:3039-3050[Abstract].
|
| 50.
|
Risco, C.,
J. L. Carrascosa,
A. M. Pedregosa,
C. D. Humphrey, and A. Sánchez-Fauquier.
1995.
Ultrastructure of the human astrovirus serotype 2.
J. Gen. Virol.
76:2075-2080[Abstract/Free Full Text].
|
| 51.
|
Risco, C.,
I. M. Antón,
C. Suñé,
A. M. Pedregosa,
J. M. Martín-Alonso,
F. Parra,
J. L. Carrascosa, and L. Enjuanes.
1995.
Membrane protein molecules of transmissible gastroenteritis coronavirus also expose the carboxy-terminal region on the external surface of the virion.
J. Virol.
69:5269-5277[Abstract].
|
| 52.
|
Risco, C.,
I. M. Antón,
L. Enjuanes, and J. L. Carrascosa.
1996.
The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins.
J. Virol.
70:4773-4777[Abstract].
|
| 52a.
| Risco, C., et al. Unpublished results.
|
| 53.
|
Rottier, P. J. M.
1995.
The coronavirus membrane glycoprotein, p. 115-139.
In
S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
|
| 54.
|
Sánchez, C. M.,
G. Jiménez,
M. D. Laviada,
I. Correa,
C. Suñé,
M. J. Bullido,
F. Gebauer,
C. Smerdou,
P. Callebaut,
J. M. Escribano, and L. Enjuanes.
1990.
Antigenic homology among coronaviruses related to transmissible gastroenteritis virus.
Virology
174:410-417[Medline].
|
| 55.
|
Saraste, J.,
G. E. Palade, and M. G. Farquhar.
1987.
Antibodies to rat pancreas Golgi subfractions: identification of a 58-kD cis-Golgi protein.
J. Cell Biol.
105:2021-2029[Abstract/Free Full Text].
|
| 56.
|
Siddell, S. G.
1995.
The Coronaviridae. An introduction, p. 1-10.
In
S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
|
| 57.
|
Spaan, W.,
D. Cavanagh, and M. C. Horzinek.
1988.
Coronaviruses: structure and genome expression.
J. Gen. Virol.
69:2939-2952[Abstract/Free Full Text].
|
| 58.
|
Spaan, W. J. M.,
P. J. Rottier,
M. C. Horzinek, and B. A. M. Van der Zeijst.
1981.
Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59).
Virology
108:424-434[Medline].
|
| 59.
|
Stohlman, S. A.,
J. O. Fleming,
C. D. Patton, and M. M. C. Lai.
1983.
Synthesis and subcellular localization of the murine coronavirus nucleocapsid protein.
Virology
130:527-532[Medline].
|
| 60.
|
Strauss, J. H.,
C. H. Calisher,
L. Dalgarno,
J. M. Dalrymple,
T. K. Frey,
R. F. Pettersson,
C. M. Rice, and W. J. M. Spaan.
1995.
Togaviridae, p. 428-433.
In
F. A. Murphy, C. M. Fauquet, D. H. L. Bishop, et al. (ed.), Virus taxonomy. Springer-Verlag, New York, N.Y.
|
| 61.
|
Sturman, I., and K. V. Holmes.
1983.
The molecular biology of coronaviruses.
Adv. Virus Res.
28:35-112[Medline].
|
| 62.
|
Tooze, J.,
S. Tooze, and G. Warren.
1984.
Replication of coronavirus MHV-A59 in sac cells: determination of the first site of budding of progeny virions.
Eur. J. Cell Biol.
33:281-293[Medline].
|
| 63.
|
Tooze, J.,
S. A. Tooze, and S. D. Fuller.
1987.
Sorting of progeny coronavirus from condensed secretory proteins at the exit from the trans-Golgi network of AtT20 cells.
J. Cell Biol.
105:1215-1226[Abstract/Free Full Text].
|
| 64.
|
Tooze, S. A.,
J. Tooze, and G. Warren.
1988.
Site of addition of N-acetyl-galactosamine to the E1 glycoprotein of mouse hepatitis virus-A59.
J. Cell Biol.
106:1475-1487[Abstract/Free Full Text].
|
| 65.
|
Turner, J. R., and A. M. Tartakoff.
1989.
The response of the Golgi complex to microtubule alterations: the roles of metabolic energy and membrane traffic in Golgi complex organization.
J. Cell Biol.
109:2081-2088[Abstract/Free Full Text].
|
| 66.
|
Vennema, H.,
G.-J. Godeke,
J. W. A. Rossen,
W. F. Voorhout,
M. C. Horzinek,
D.-J. E. Opsteltein, and P. J. M. Rottier.
1996.
Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes.
EMBO J.
15:2020-2028[Medline].
|
| 67.
|
Yu, X.,
W. Bi,
S. R. Weiss, and J. L. Leibowitz.
1994.
Mouse hepatitis virus gene 5b protein is a new virion envelope protein.
Virology
202:1018-1023[Medline].
|
J Virol, May 1998, p. 4022-4031, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Barcena, M., Oostergetel, G. T., Bartelink, W., Faas, F. G. A., Verkleij, A., Rottier, P. J. M., Koster, A. J., Bosch, B. J.
(2009). Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc. Natl. Acad. Sci. USA
106: 582-587
[Abstract]
[Full Text]
-
Schaecher, S. R., Diamond, M. S., Pekosz, A.
(2008). The Transmembrane Domain of the Severe Acute Respiratory Syndrome Coronavirus ORF7b Protein Is Necessary and Sufficient for Its Retention in the Golgi Complex. J. Virol.
82: 9477-9491
[Abstract]
[Full Text]
-
Jayaram, H., Fan, H., Bowman, B. R., Ooi, A., Jayaram, J., Collisson, E. W., Lescar, J., Prasad, B. V. V.
(2006). X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation.. J. Virol.
80: 6612-6620
[Abstract]
[Full Text]
-
Calvo, E., Escors, D., Lopez, J. A., Gonzalez, J. M., Alvarez, A., Arza, E., Enjuanes, L.
(2005). Phosphorylation and subcellular localization of transmissible gastroenteritis virus nucleocapsid protein in infected cells. J. Gen. Virol.
86: 2255-2267
[Abstract]
[Full Text]
-
Hogan, R. J., Gao, G., Rowe, T., Bell, P., Flieder, D., Paragas, J., Kobinger, G. P., Wivel, N. A., Crystal, R. G., Boyer, J., Feldmann, H., Voss, T. G., Wilson, J. M.
(2004). Resolution of Primary Severe Acute Respiratory Syndrome-Associated Coronavirus Infection Requires Stat1. J. Virol.
78: 11416-11421
[Abstract]
[Full Text]
-
Schwegmann-Wessels, C., Al-Falah, M., Escors, D., Wang, Z., Zimmer, G., Deng, H., Enjuanes, L., Naim, H. Y., Herrler, G.
(2004). A Novel Sorting Signal for Intracellular Localization Is Present in the S Protein of a Porcine Coronavirus but Absent from Severe Acute Respiratory Syndrome-associated Coronavirus. J. Biol. Chem.
279: 43661-43666
[Abstract]
[Full Text]
-
Gallego-Gomez, J. C., Risco, C., Rodriguez, D., Cabezas, P., Guerra, S., Carrascosa, J. L., Esteban, M.
(2003). Differences in Virus-Induced Cell Morphology and in Virus Maturation between MVA and Other Strains (WR, Ankara, and NYCBH) of Vaccinia Virus in Infected Human Cells. J. Virol.
77: 10606-10622
[Abstract]
[Full Text]
-
Kuo, L., Masters, P. S.
(2003). The Small Envelope Protein E Is Not Essential for Murine Coronavirus Replication. J. Virol.
77: 4597-4608
[Abstract]
[Full Text]
-
Salanueva, I. J., Novoa, R. R., Cabezas, P., Lopez-Iglesias, C., Carrascosa, J. L., Elliott, R. M., Risco, C.
(2002). Polymorphism and Structural Maturation of Bunyamwera Virus in Golgi and Post-Golgi Compartments. J. Virol.
77: 1368-1381
[Abstract]
[Full Text]
-
Ortego, J., Escors, D., Laude, H., Enjuanes, L.
(2002). Generation of a Replication-Competent, Propagation-Deficient Virus Vector Based on the Transmissible Gastroenteritis Coronavirus Genome. J. Virol.
76: 11518-11529
[Abstract]
[Full Text]
-
Kuo, L., Masters, P. S.
(2002). Genetic Evidence for a Structural Interaction between the Carboxy Termini of the Membrane and Nucleocapsid Proteins of Mouse Hepatitis Virus. J. Virol.
76: 4987-4999
[Abstract]
[Full Text]
-
Risco, C., Rodriguez, J. R., Lopez-Iglesias, C., Carrascosa, J. L., Esteban, M., Rodriguez, D.
(2002). Endoplasmic Reticulum-Golgi Intermediate Compartment Membranes and Vimentin Filaments Participate in Vaccinia Virus Assembly. J. Virol.
76: 1839-1855
[Abstract]
[Full Text]
-
Heljasvaara, R., Rodriguez, D., Risco, C., Carrascosa, J. L., Esteban, M., Rodriguez, J. R.
(2001). The Major Core Protein P4a (A10L Gene) of Vaccinia Virus Is Essential for Correct Assembly of Viral DNA into the Nucleoprotein Complex To Form Immature Viral Particles. J. Virol.
75: 5778-5795
[Abstract]
[Full Text]
-
Escors, D., Ortego, J., Laude, H., Enjuanes, L.
(2001). The Membrane M Protein Carboxy Terminus Binds to Transmissible Gastroenteritis Coronavirus Core and Contributes to Core Stability. J. Virol.
75: 1312-1324
[Abstract]
[Full Text]
-
Bost, A. G., Carnahan, R. H., Lu, X. T., Denison, M. R.
(2000). Four Proteins Processed from the Replicase Gene Polyprotein of Mouse Hepatitis Virus Colocalize in the Cell Periphery and Adjacent to Sites of Virion Assembly. J. Virol.
74: 3379-3387
[Abstract]
[Full Text]
-
Kuo, L., Godeke, G.-J., Raamsman, M. J. B., Masters, P. S., Rottier, P. J. M.
(2000). Retargeting of Coronavirus by Substitution of the Spike Glycoprotein Ectodomain: Crossing the Host Cell Species Barrier. J. Virol.
74: 1393-1406
[Abstract]
[Full Text]
-
Salanueva, I. J., Carrascosa, J. L., Risco, C.
(1999). Structural Maturation of the Transmissible Gastroenteritis Coronavirus. J. Virol.
73: 7952-7964
[Abstract]
[Full Text]
-
Lim, K. P., Liu, D. X.
(2001). The Missing Link in Coronavirus Assembly. RETENTION OF THE AVIAN CORONAVIRUS INFECTIOUS BRONCHITIS VIRUS ENVELOPE PROTEIN IN THE PRE-GOLGI COMPARTMENTS AND PHYSICAL INTERACTION BETWEEN THE ENVELOPE AND MEMBRANE PROTEINS. J. Biol. Chem.
276: 17515-17523
[Abstract]
[Full Text]